About Dr. Chernoff’s Clinical Research, Lectures and Publications
Dr. Chernoff is committed to research and advancing the field of medical aesthetics. He is continuously involved in multiple research projects to analyze the effectiveness or expansion of treatments. Dr. Chernoff continues to conduct alpha and beta testing for medical and biotech companies. This is the testing that is used in the clinical trial phase for a therapy or technology prior to FDA approval. Companies use Dr. Chernoff’s research data to submit these therapies or technologies for FDA approval.
Early access to new therapies and technologies give Dr. Chernoff additional experience and expertise. Dr. Chernoff not only offers these treatments to his patients early but has expertise in the technique required to administrate the treatments to patients.
Dr. Chernoff was one of the original clinical research investigators for injectable fibroblast therapy. His ongoing research in the exciting field of cellular medicine is providing insight into expanded treatment indications such as acne scars, non-healing wounds, burn scars, and traumatic injury scars.
Dr. Chernoff has authored numerous scientific papers and medical laser textbook chapters. He has given over 600 lectures to physicians around the world on both surgical and non-surgical therapy. Dr. Chernoff has been featured on news programs such as Dateline NBC, ABC and CBS Nightly News, BBC World News, and in Time, Newsweek and W Magazines. He discusses his research and the latest advancements in cosmetic surgery, laser therapy, and injectable fibroblast therapy.
Dr. Chernoff is the founder of the Victims of Violence Foundation, providing new treatments for patients who have been victims of violence, abuse, injury, or illness.
Plastic Surgery Research Areas & Studies:
Learn about Dr. Chernoff’s upcoming and recent lectures at scientific meetings and conferences.
Contact 317-573-8899 (Indianapolis, IN Office) or 707.544.3232 (Santa Rosa, CA Office) to learn more about the investigatory and clinical studies available.